TH.TO
Theratechnologies Inc
Price:  
1.70 
CAD
Volume:  
33,703.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TH.TO EV/EBITDA

149.0%
Upside

As of 2024-12-04, the EV/EBITDA ratio of Theratechnologies Inc (TH.TO) is 7.97. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TH.TO's latest enterprise value is 104.74 mil CAD. TH.TO's TTM EBITDA according to its financial statements is 13.14 mil CAD. Dividing these 2 quantities gives us the above TH.TO EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 8.7x - 12.4x 10.6x
Forward P/E multiples 8.8x - 18.2x 13.5x
Fair Price 2.91 - 6.70 4.23
Upside 71.2% - 293.9% 149.0%
1.70 CAD
Stock Price
4.23 CAD
Fair Price

TH.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-11-29 7.39
2024-11-28 7.39
2024-11-27 7.32
2024-11-26 7.53
2024-11-25 7.32
2024-11-22 7.29
2024-11-21 7.32
2024-11-20 7.39
2024-11-19 7.32
2024-11-18 7.43
2024-11-15 7.29
2024-11-14 7.32
2024-11-13 7.50
2024-11-12 7.53
2024-11-11 7.64
2024-11-08 7.67
2024-11-07 7.81
2024-11-06 7.64
2024-11-05 7.67
2024-11-04 7.36
2024-11-01 7.32
2024-10-31 7.36
2024-10-30 7.57
2024-10-29 7.43
2024-10-28 7.50
2024-10-25 7.64
2024-10-24 7.43
2024-10-23 7.81
2024-10-22 7.81
2024-10-21 8.02
2024-10-18 7.85
2024-10-17 7.60
2024-10-16 7.60
2024-10-15 7.57
2024-10-11 7.53
2024-10-10 7.57
2024-10-09 7.29
2024-10-08 7.15
2024-10-07 7.39
2024-10-04 7.22
2024-10-03 7.25
2024-10-02 7.25
2024-10-01 7.15
2024-09-30 7.36
2024-09-27 7.15
2024-09-26 7.32
2024-09-25 7.04
2024-09-24 7.08
2024-09-23 7.29
2024-09-20 7.39